Emerging Roles for PAX Transcription Factors in Cancer Biology

General Physiology and Biophysics

Volumn 17, Issue 3, 1998, Pages 211-224

  Schafer B W ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Apoptosis; Oncogenes; PAX genes; Rhabdomyosarcoma; Wilms' tumor

Indexed keywords

TRANSCRIPTION FACTOR;

BRAIN TUMOR; CELL TRANSFORMATION; GENETICS; HUMAN; KIDNEY TUMOR; LYMPHOMA; METABOLISM; NEOPLASM; NEPHROBLASTOMA; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RHABDOMYOSARCOMA;

BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; LYMPHOMA; NEOPLASMS; RHABDOMYOSARCOMA; TRANSCRIPTION FACTORS; WILMS TUMOR;

EID: 0032150213     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Amicone L., Spagnoli F. M., Spath G., Giordano S., Tommasini C., Bernardini S., DeLuca V., DellaRocca C., Weiss M. C., Comoglio P. M., Tripodi M. (1997): Transgenic expression in the liver of truncated met blocks apoptosis and permits immortalization of hepatocytes. EMBO J. 16, 495-503
2. Anastasi S., Giordano S., Sthandier O., Gambarotta G., Maione R., Comoglio P., Amati P. (1997): A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive met kinase activation on myogenic differentiation. J. Cell Biol. 137, 1057-1068
3. Attardi L. D., Lowe S. W., Brugarolas J., Jacks T. (1996): Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15, 3693-3701
4. Balling R , Deutsch U., Gruss P. (1988): Undulated, a mutation affecting the development of the mouse skeleton, has a point mutation in the paired box of Pax 1. Cell 55, 531-535
5. Bennicelli J. L., Fredericks W. J., Wilson R. B., Rauscher F. J., Barr F. G. (1995): Wild type Pax3 protein and the Pax3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 11, 119-130
6. Bernasconi M., Remppis A., Fredericks W. J., Rauscher F. J. I., Schäfer B. W. (1996): Induction of apoptosis in rhabdomyosaxcoma cells through down-regulation of PAX proteins. Proc. Natl. Acad. Sci. USA 93, 13164-13169
7. Bober E., Franz T., Arnold H. H., Gruss P., Tremblay P. (1994): Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120, 603-612
8. Bopp D., Burri M., Baumgertner S., Frigerio G., Noll M. (1986): Conservation of a large protein domain in the segmentation gene paired and in functionally related genes of Drososphila. Cell 47, 1033-1040
9. Busslinger M., Klix N., Pfeffer P., Graninger P. G., Kozmik Z. (1996): Deregulation of PAX-5 by translocation of the Eμ enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc. Natl. Acad. Sci. USA 93, 6129-6134
10. Cooper C. S., Park M., Blair D., Tainsky K., Huebner C. M., Croce C. M., Vande Woude G. F. (1984): Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311, 29-33
11. Davis R. J., Barr F. G. (1997): Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 94, 8047-8051
12. Davis R. J., D'Cruz C. M., Lovell M. A., Biegel J. A., Barr F. G. (1994): Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54, 2869-2872
13. Dressier G. R., Douglass E. C. (1992): Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilm's tumor. Proc. Natl. Acad. Sci. USA 89, 1179-1183
14. Epstein D. J., Vekemans M., Gros P. (1991): Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67, 767-774
15. Epstein J. A., Lam P., Jepeal L., Maas R. L., Shapiro D. N. (1995): Pax3 inhibits myogenic differentiation of cultured myoblast cells. J. Biol. Chem. 270, 11719-11722
16. Fabbro D., Diloreto C., Beltrami C. A., Belfiore A., Dilauro R., Damante G. (1994): Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res. 54, 4744-4749
17. Fredericks W. J., Galili M., Mukhopadhyay S., Rovera G., Bennicelli J. G., Barr F., Rauscher F. J. (1995): The PAX3/FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 15, 1522-1535
18. Galili N., Davis R. J., Fredericks W. J., Mukhopadhyay S., Rauscher F. J., Emanuel B. S., Rovera G., Barr F. G. (1993): Fusion of a forkhead domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5, 230-235
19. Gnarra J. R., Dressier G. R. (1995): Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 55, 4092-4098
20. Hewitt S. M., Hamada S., Monarres A., Kottical L. V., Saunders G. F., McDonnell T. J. (1997): Transcriptional activation of the bcl-2 apoptosis suppressor gene by the paired box transcription factor pax8. Anticancer Res. 17, 3211-3215
21. Hill R. E., Favor J., Hogan B. L. M., Ton C. C. T., Saunders G. F., Hanson I. M., Prosser J., Jordan T., Hastie N. D., van Heyningen V. (1991): Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 354, 522-525
22. Hueber A. O., Zornig M., Lyon D., Suda T., Nagata S., Evan G. I. (1997): Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis. Science 278, 1305-1309
23. Kelly K. M., Womer R. B., Sorensen P. H. B., Xiong Q. B., Barr F. G. (1997): Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J. Clin. Oncol. 15, 1831-1836
24. Kozmik Z., Sure U., Ruedi D., Busslinger M., Aguzzi A. (1995): Deregulated expression of Pax5 in medulloblastoma. Proc. Natl. Acad. Sci. USA 92, 5709-5713
25. Maroto M., Reshef R., Munsterberg A. E., Koester S., Goulding M., Lassar A. B. (1997): Ectopic Pax-3 activates myod and myf-5 expression in embryonic mesoderm and neural tissue. Cell 89, 139-148
26. Maulbecker C. C., Gruss P. (1993): The oncogenic potential of Pax genes. EMBO J. 12, 2361-2367
27. McConnell M. J., Cunliffe H. E., Chua L, J., Ward T. A., Eccles M. R. (1997): Differential regulation of the human Wilm's-tumour suppressor gene (wti) promoter by two isoforms of Pax2. Oncogene 14, 2689-2700
28. O'Connor R., Kauffmann-Zeh A., Liu Y., Lehar S., Evan G. I., Baserga R., Blattler W. A. (1997): Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol. 17, 427-435
29. Poleev A., Fickenscher H., Mundlos S., Winterpracht A., Zabel B., Fidler A., Gruss P., Plachov D. (1992): PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development 116, 611-623
30. Rossi D. L., Acebron A., Santisteban P. (1995): Function of the homeo and paired domain proteins Ttf-1 and Pax-8 in thyroid cell proliferation. J. Biol. Chem. 270, 23139-23142
31. Schäfer B. W., Czerny T., Bernasconi M., Genini M., Busslinger M. (1994): Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes. Nucl. Acid. Res. 22, 4574-4582
32. Scheidler S., Fredericks W. J., Rauscher F. J., Barr F. G., Vogt P. K. (1996): The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Proc. Natl. Acad. Sci. USA 93, 9805-9809
33. Schmidt L., Duh F. M., Chen F., Kishida T., Glenn G., Choyke P., Scherer S. W., Zhuang Z. (1997): Germline and somatic mutations in the tyrosine kinase domain of the met proto-oncogene in papillary renal carcinomas. Nat. Genet. 16, 68-73
34. Schulte T. W., Toretsky J. A., Ress E., Helman L., Neckers L. M. (1997): Expression of pax3 in Ewing's-sarcoma family of tumors. Biochem. Mol. Med. 60, 121-126
35. Shapiro D. N., Sublett J. E., Li B. T., Downing J. R., Naeve C. W. (1993): Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53, 5108-5112
36. Soman N., Correra P., Ruiz B., Wogan G. (1991): The tpr-met oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc. Natl. Acad. Sci. USA 88, 4892-4896
37. Stuart E. T., Kioussi C., Gruss P. (1994): Mammalian pax genes. Annu. Rev. Genet. 28, 219-236
38. Stuart E. T., Haffner R., Oren M., Gruss P. (1995a): Loss of p53 function through Pax-mediated transcriptional repression. EMBO J. 14, 5638-5645
39. Stuart E. T., Kioussi C., Aguzzi A., Gruss P. (1995b): PAX5 expression correlates with increasing malignancy in human astrocytomas. Clin. Cancer Res. 1, 207-214
40. Sun H. M., Rodin A., Zhou Y. H., Dickinson D. P., Harper D. E., Hewettemmett D., Li W. H. (1997): Evolution of paired domains - isolation and sequencing of jellyfish and hydra pax genes related to pax-5 and pax-6. Proc. Natl. Acad. Sci. USA 94, 5156-5161
41. Tajbakhsh S., Rocancourt D., Cossu G., Buckingham M. (1997): Redefining the genetic hierarchies controlling skeletal myogenesis - pax-3 and myf-5 act upstream of myod. Cell 89, 127-138
42. Wiggan O., Taniguchisidle A., Hamel P. A. (1998): Interaction of the pRB-family proteins with factors containing paired-like homeodomains. Oncogene 16, 227-236